Recalls & Warnings April 26, 2013 Seller of Immune, Cholesterol, Liver and Blood Sugar Products Warned For Drug Claims On March 20, 2013, the FDA issued a warning letter to Birkdale Medicinals LLC, following a review of the company's website which found statements made about Birkdale products, including Immune Response 247, Cholestat, Silymarin 81 and LevelStat, to be drug claims
BPC-157 injections can be split between levels if needed, though the total daily dose should remain within standard protocol ranges
Rapid use is recommended to ensure data accuracy
The information presented here is for educational and informational purposes and is based on preclinical research findings
DOI:10.4103/1673-5374.320969